{
    "summary": "Skip to main navigation\n\nClose\n\nMenu\n\n## Main navigation\n\n  * Advocacy\n    * Issue Overview\n    * #Rx4StateSavings\n    * #4GRxANTED \n    * #MarkupMadness\n    * State Advocacy\n    * GDUFA/BsUFA User Fees\n    * Biosimilars Council\n    * Action Center\n  * Our Impact\n  * Join\n  * About Us\n    * Generic Quality\n    * About AAM\n    * Our Team\n    * Our Members\n    * Generic Medicines\n    * Biosimilars Council\n    * Meet Our Board\n    * Social Commitment\n    * Careers\n    * Contact Us\n  * Stories\n  * Events\n  * Resources\n    * All Resources\n    * Press Release\n    * Drug Shortages White Paper\n    * 2023 Savings Report\n    * Supply Chain Blueprint\n    * Biosimilars Patient Resource Center\n    * Biosimilar Research & Studies\n    * Blog\n    * Founders Blogs\n    * Amicus Briefs\n  * Take Action\n\n**New White Paper** \\- Read AAM Report on Drug Shortages\n\nLearn More\n\nClose\n\n  * Coming to Access! 2024?\n\nMeet the leaders and decision-makers who are shaping the future of generics\nand biosimilars. February 5\u20137, 2024, Tampa, Florida.\n\nWatch Video\n\n  * Jamie Metzl, Tech & Healthcare Visionary to Speak at Access! 2024\n\nBe part of the conversation at Access! 2024 as Jamie Metzl shares insights on\nthe evolving landscape of technology and healthcare.\n\nRegister today!\n\n  * America\u2019s Most Exciting Biologics Event\n\nAAM and its Biosimilars Council are official partners of the Festival of\nBiologics, held in San Diego, California, April 15\u201317. The conference brings\ntogether pharma and biotech, academics, research institutes, and their\npartners across the value chain to discuss the discovery, development,\nmanufacturing, pricing, market access, clinical trials, and commercialization\nof biological drugs.\n\nBook Your Ticket Now\n\n  * NEW: 2023 U.S. Generic & Biosimilar Medicines Savings Report\n\nSavings continue to grow with $408 billion saved in 2022 for the U.S. health\ncare system, including patients, employers and taxpayers. Representing 90% of\nRx filled but less than 18% of spending, generics and biosimilars are an\nintegral part of the U.S. health care system.\n\nRead Press Release\n\n  * What Do You Take #4GRxANTED?\n\nThe generic and biosimilar industry is working with Direct Relief to donate\ndoses of medicines across the U.S. to people in need. You can be part of this\ncollective effort by recording a short video on what you take for granted and\nsharing on social media with #4GRxANTED and @4GRxANTED.\n\nLearn More\n\n  * PBMs Are Blocking Patient Access to Biosimilar Insulin\n\nA new report from AAM\u2019s Biosimilars Council shows that even as patient demand\nfor biosimilar insulin has grown dramatically, PBMs are continuing to restrict\npatient access and drive up drug prices.\n\nRead Blog\n\n  * \"You guys make such a huge difference that you don't get credit for.\"\n\nMark Cuban on generic medicines.\n\nView Video\n\n  1. 1\n  2. 2\n  3. 3\n  4. 4\n  5. 5\n  6. 6\n  7. 7\n\n  * Previous\n  * Next\n\n### Working to leave a positive impact on...\n\nIndustry We promote competition in the pharmaceutical industry by lowering\nbarriers to entry for manufacturers of generic and biosimilar medicines and\ncombatting anti-competitive abuses by some brand drug companies who put\nprofits before patients. **Learn More**\n\nPeople We measure our success as an industry by the lives we impact. We work\nto protect the low cost of generic and biosimilar medicines and to drive down\nthe cost of developing new ones, expanding access to as many people as\npossible. **Learn More**\n\nPolicy We are a trusted partner and established authority within the\npharmaceutical field. We provide accurate, timely data to educate policymakers\nand promote general public knowledge regarding the positive impact of\naffordable generic and biosimilar medicines. **Learn More**\n\n# About Us\n\nThe Association for Accessible Medicines improves access to safe, quality,\neffective medicine. Better access to medicine is relevant to everybody\nbecause, after all, we\u2019re all patients at some point.\n\nHealth is the foundation for everything in life. Healthy people are better\nable to reach their full potential. Generics and biosimilars help more people\nin more places live healthier and longer.\n\nWho We Are\n\n##  Recent Updates\n\nView All\n\nAmicus Briefs\n\nBlog\n\nPress Release\n\nVideos\n\nTweets\n\nFact Sheet\n\nPresentation\n\nReports\n\nBrands and Campaigns\n\nPress Release\n\n**Jan 23, 2024** | Brian Hart\n\nKeren Haruvi Named Chair of the Association for Accessible Medicines Board of\nDirectors\n\nPress Release\n\n**Jan 23, 2024** | Brian Hart\n\nAAM Requests Federal Injunction to Block Illinois\u2019 Unconstitutional Drug Price\nLaw\n\nPress Release\n\n**Dec 8, 2023** | Brian Hart\n\nKeren Haruvi Announced as Chair of the Association for Accessible Medicines\nBoard of Directors\n\nPress Release\n\n**Nov 15, 2023** | Brian Hart\n\nAAM Statement on IQVIA Institute Report Examining Drug Shortages\n\nVideo\n\n**Nov 3, 2023** | Jennifer Soup\n\nJoin Us at Access! 2024 in Tampa, Florida\n\nBlog\n\n**Oct 20, 2023** | AAM\n\n2023 Report\n\n  * Load More\n\nGenerics are a proven prescription for a healthier society. Generic and\nbiosimilar medicines make it easier and more affordable for patients to live\nhealthier lives. Learn More\n\n##  Our Brands and Campaigns\n\n##  Our Brands and Campaigns\n\n**Association for Accessible Medicines**\n\n601 New Jersey Ave NW, Suite 850  \nWashington DC 20001\n\n\n\n202.249.7100\n\ninfo@accessiblemeds.org\n\n## Main navigation\n\n  * Advocacy\n  * Our Impact\n  * Join\n  * About Us\n  * Stories\n  * Events\n  * Resources\n  * Take Action\n\n\u00a9 2023 Association for Accessible Medicines (AAM), All Rights Reserved  \nPrivacy Policy  |  Terms of Use  |  Contact\n\n##  Sign-up for Updates\n\nReceive relevant industry news, event information and the latest resources on\nbiosimilars and generic medicines.\n\nSubscribe\n\n##  Stay Connected\n\nFor the latest updates, follow us on social media.\n\n__\n\n__\n\n__\n\n__\n\n__\n\nClose\n\nMenu\n\n  * Advocacy\n  * Our Impact\n  * Join\n  * About Us\n  * Stories\n  * Events\n  * Resources\n  * Take Action\n\nAdvocacy\n\n  * Issue Overview\n  * #Rx4StateSavings\n  * #4GRxANTED \n  * #MarkupMadness\n  * State Advocacy\n  * GDUFA/BsUFA User Fees\n  * Biosimilars Council\n  * Action Center\n\nAbout Us\n\n  * Generic Quality\n  * About AAM\n  * Our Team\n  * Our Members\n  * Generic Medicines\n  * Biosimilars Council\n  * Meet Our Board\n  * Social Commitment\n  * Careers\n  * Contact Us\n\nEvents\n\n  * Access! 2024\n  * GRx+Biosims 2023\n\nResources\n\n  * All Resources\n  * Press Release\n  * Drug Shortages White Paper\n  * 2023 Savings Report\n  * Supply Chain Blueprint\n  * Biosimilars Patient Resource Center\n  * Biosimilar Research & Studies\n  * Blog\n  * Founders Blogs\n  * Amicus Briefs\n\n",
    "links": "[{\"link\": \"https://accessiblemeds.org/\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/advocacy\", \"text\": \"Advocacy\"}, {\"link\": \"https://accessiblemeds.org/advocacy\", \"text\": \"Issue Overview\"}, {\"link\": \"https://accessiblemeds.org/rx4statesavings\", \"text\": \"#Rx4StateSavings\"}, {\"link\": \"https://accessiblemeds.org/advocacy/state-legislation\", \"text\": \"State Advocacy\"}, {\"link\": \"https://accessiblemeds.org/advocacy/gdufa-bsufa-user-fees\", \"text\": \"GDUFA/BsUFA User Fees\"}, {\"link\": \"https://accessiblemeds.org/our-impact\", \"text\": \"Our Impact\"}, {\"link\": \"https://accessiblemeds.org/join\", \"text\": \"Join\"}, {\"link\": \"https://accessiblemeds.org/about\", \"text\": \"About Us\"}, {\"link\": \"https://accessiblemeds.org/take-with-confidence\", \"text\": \"Generic Quality\"}, {\"link\": \"https://accessiblemeds.org/our-members\", \"text\": \"Our Members\"}, {\"link\": \"https://accessiblemeds.org/generic-medicines\", \"text\": \"Generic Medicines\"}, {\"link\": \"https://accessiblemeds.org/about/our-board\", \"text\": \"Meet Our Board\"}, {\"link\": \"https://accessiblemeds.org/beyond-access-aams-social-commitment-and-partners\", \"text\": \"Social Commitment\"}, {\"link\": \"https://accessiblemeds.org/careers\", \"text\": \"Careers\"}, {\"link\": \"https://accessiblemeds.org/contact-us\", \"text\": \"Contact Us\"}, {\"link\": \"https://accessiblemeds.org/patient-stories\", \"text\": \"Stories\"}, {\"link\": \"https://accessiblemeds.org/events\", \"text\": \"Events\"}, {\"link\": \"https://accessiblemeds.org/resources\", \"text\": \"Resources\"}, {\"link\": \"https://accessiblemeds.org/resources\", \"text\": \"All Resources\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases\", \"text\": \"Press Release\"}, {\"link\": \"https://accessiblemeds.org/resources/reports/aam-white-paper-shortages\", \"text\": \"Drug Shortages White Paper\"}, {\"link\": \"https://accessiblemeds.org/resources/blog/2023-savings-report\", \"text\": \"2023 Savings Report\"}, {\"link\": \"https://accessiblemeds.org/resources/reports/blueprint-enhancing-security-us-pharmaceutical-supply-chain\", \"text\": \"Supply Chain Blueprint\"}, {\"link\": \"https://accessiblemeds.org/resources/blog\", \"text\": \"Blog\"}, {\"link\": \"https://accessiblemeds.org/founders-series\", \"text\": \"Founders Blogs\"}, {\"link\": \"https://accessiblemeds.org/resources/amicus\", \"text\": \"Amicus Briefs\"}, {\"link\": \"https://accessiblemeds.org/take-action\", \"text\": \"Take Action\"}, {\"link\": \"https://accessiblemeds.org/resources/reports/aam-white-paper-shortages\", \"text\": \"Learn More\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases/generic-biosimilar-drugs-generate-408-billion-savings-2022\", \"text\": \"Read Press Release\"}, {\"link\": \"https://accessiblemeds.org/resources/blog/pharmacy-benefit-managers-blocking-patient-access-biosimilar-insulin\", \"text\": \"Read Blog\"}, {\"link\": \"https://accessiblemeds.org/patient-stories\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/advocacy\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/about\", \"text\": \"Who We Are\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases/keren-haruvi-named-chair-association-accessible-medicines-board-directors\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases/aam-requests-federal-injunction-block-illinois-unconstitutional-drug-price\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases/keren-haruvi-announced-board-chair-aam\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases/AAM-statement-IQVIA-report-drug-shortages\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/resources/blog/2023-savings-report\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/Rx4Savings\", \"text\": \"\"}, {\"link\": \"https://accessiblemeds.org/advocacy\", \"text\": \"Advocacy\"}, {\"link\": \"https://accessiblemeds.org/our-impact\", \"text\": \"Our Impact\"}, {\"link\": \"https://accessiblemeds.org/join\", \"text\": \"Join\"}, {\"link\": \"https://accessiblemeds.org/about\", \"text\": \"About Us\"}, {\"link\": \"https://accessiblemeds.org/patient-stories\", \"text\": \"Stories\"}, {\"link\": \"https://accessiblemeds.org/events\", \"text\": \"Events\"}, {\"link\": \"https://accessiblemeds.org/resources\", \"text\": \"Resources\"}, {\"link\": \"https://accessiblemeds.org/take-action\", \"text\": \"Take Action\"}, {\"link\": \"https://accessiblemeds.org/privacy-policy\", \"text\": \"Privacy Policy\"}, {\"link\": \"https://accessiblemeds.org/aam-terms-use\", \"text\": \"Terms of Use\"}, {\"link\": \"https://accessiblemeds.org/contact-us\", \"text\": \"Contact\"}, {\"link\": \"https://accessiblemeds.org/advocacy\", \"text\": \"Advocacy\"}, {\"link\": \"https://accessiblemeds.org/our-impact\", \"text\": \"Our Impact\"}, {\"link\": \"https://accessiblemeds.org/join\", \"text\": \"Join\"}, {\"link\": \"https://accessiblemeds.org/about\", \"text\": \"About Us\"}, {\"link\": \"https://accessiblemeds.org/patient-stories\", \"text\": \"Stories\"}, {\"link\": \"https://accessiblemeds.org/events\", \"text\": \"Events\"}, {\"link\": \"https://accessiblemeds.org/resources\", \"text\": \"Resources\"}, {\"link\": \"https://accessiblemeds.org/take-action\", \"text\": \"Take Action\"}, {\"link\": \"https://accessiblemeds.org/advocacy\", \"text\": \"Issue Overview\"}, {\"link\": \"https://accessiblemeds.org/rx4statesavings\", \"text\": \"#Rx4StateSavings\"}, {\"link\": \"https://accessiblemeds.org/advocacy/state-legislation\", \"text\": \"State Advocacy\"}, {\"link\": \"https://accessiblemeds.org/advocacy/gdufa-bsufa-user-fees\", \"text\": \"GDUFA/BsUFA User Fees\"}, {\"link\": \"https://accessiblemeds.org/take-with-confidence\", \"text\": \"Generic Quality\"}, {\"link\": \"https://accessiblemeds.org/our-members\", \"text\": \"Our Members\"}, {\"link\": \"https://accessiblemeds.org/generic-medicines\", \"text\": \"Generic Medicines\"}, {\"link\": \"https://accessiblemeds.org/about/our-board\", \"text\": \"Meet Our Board\"}, {\"link\": \"https://accessiblemeds.org/beyond-access-aams-social-commitment-and-partners\", \"text\": \"Social Commitment\"}, {\"link\": \"https://accessiblemeds.org/careers\", \"text\": \"Careers\"}, {\"link\": \"https://accessiblemeds.org/contact-us\", \"text\": \"Contact Us\"}, {\"link\": \"https://accessiblemeds.org/events/access-2024\", \"text\": \"Access! 2024\"}, {\"link\": \"https://accessiblemeds.org/resources\", \"text\": \"All Resources\"}, {\"link\": \"https://accessiblemeds.org/resources/press-releases\", \"text\": \"Press Release\"}, {\"link\": \"https://accessiblemeds.org/resources/reports/aam-white-paper-shortages\", \"text\": \"Drug Shortages White Paper\"}, {\"link\": \"https://accessiblemeds.org/resources/blog/2023-savings-report\", \"text\": \"2023 Savings Report\"}, {\"link\": \"https://accessiblemeds.org/resources/reports/blueprint-enhancing-security-us-pharmaceutical-supply-chain\", \"text\": \"Supply Chain Blueprint\"}, {\"link\": \"https://accessiblemeds.org/resources/blog\", \"text\": \"Blog\"}, {\"link\": \"https://accessiblemeds.org/founders-series\", \"text\": \"Founders Blogs\"}, {\"link\": \"https://accessiblemeds.org/resources/amicus\", \"text\": \"Amicus Briefs\"}]"
}